Sources Sought
Inhaled Nitric Oxide
Dept of Defense · Defense Health Agency (DHA) · Sol. HT940827Q0002
Due in 11 days
- Response due
- Oct 22, 2026, 5:00 PM CDT · 6:00 PM Eastern
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Place
- JBSA FT Sam Houston, TX
AI summary Beta
The Defense Health Agency plans to buy inhaled nitric oxide, the delivery device and support services for Brooke Army Medical Center in San Antonio, Texas, from INO Therapeutics LLC without competition. It is asking whether any other company can meet the needs. The term is January 1 to December 31, 2027, plus four option years.
Things to watch
- Serious: Sole-source intent. The Government has already picked INO Therapeutics, so a competitor must prove that competition would help the Government. From the notice:
…intends to award a sole source contract in accordance with RFO FAR 8.104 (Use of Existing Contracts) to INO THERAPEUTICS LLC…
- Serious: Bundle of drug, device and logistics. You would need to supply a specific drug, a matching delivery device and support services together, which few small firms can do. From the notice:
…a specialized Delivery Device that meets the precise criteria outlined in the iNO product label for safe and effective administration…
- Worth checking: Burden of proof on respondents. Responses must show competition would not be cost or schedule prohibitive. From the notice:
…would be beneficial to the Government and would not be cost or schedule prohibitive…
Read from the notice text only.
Full brief
What they want
- Supply nitric oxide gas for inhalation at 800 parts per million
- Provide a delivery device that meets the criteria in the iNO product label
- Provide maintenance and calibration items, accessories and disposable supplies
- Provide support services: training, maintenance, pick-up and delivery logistics
- Period of performance
- 1 Jan 2027 - 31 Dec 2027, plus 4 option years
- Place of performance
- Brooke Army Medical Center, JBSA Fort Sam Houston, Texas (Department of Medicine)
- Contract vehicle
- Existing contract, under FAR 8.104 (Use of Existing Contracts)
- Offers due
- October 22, 2026 by 12:00 PM CST (the SAM deadline field shows 5:00 PM UTC-05:00)
- How to submit
- Written response by email to Contracting Officer Joe D. Wells at joe.d.wells3.civ@health.mil
What to include when you submit
- Show demonstrated capability to meet all technical requirements
- Include clear and convincing evidence that competition would be beneficial and not cost or schedule prohibitive
- Mark any proprietary information; responses will not be returned
You must have
- Demonstrated capability to meet all technical requirements in the notice From the notice:
Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit…
Current contractor
INO Therapeutics LLC is named as the intended sole-source awardee under an existing contract.
Not in the notice text
- Quantities of gas and number of devices
- Full technical requirements beyond the short summary
- Estimated value
- Contract type
- Which existing contract the order would use
Key facts
- Response due
- Oct 22, 2026, 5:00 PM CDT · 6:00 PM Eastern
- Posted
- Oct 8, 2026
- Notice type
- Sources Sought
- Solicitation number
- HT940827Q0002
- Agency
- Dept of Defense · Defense Health Agency (DHA)
- Office
- Defense Health Agency, San Antonio, TX
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product/service code
- 6505 · Drugs and Biologicals
- Business type
- Medical & healthcare
- Place of performance
- JBSA FT Sam Houston, TX
- Contracting contact
- Dulce BaresJoe Wells
- Attachments
Past awards and competition
Who has won work like this before, the likely incumbent, and what similar contracts paid, from USAspending.gov.
Before you respond
Terms on this notice: Sources sought notice
Full notice text from SAM.gov
NOTICE OF INTENT TO SOLE SOURCE: The Defense Health Agency – Healthcare Contracting Division – South, intends to award a sole source contract in accordance with RFO FAR 8.104 (Use of Existing Contracts) to INO THERAPEUTICS LLC, to procure delivery of Inhaled Nitric Oxide (iNO) for use at the Department of Medicine. at Brooke Army Medical Center, Fort Sam Houston, Texas. The period of performance is 01 JAN 2027 – 31 DEC 2027, plus four (4) option years. This notice serves to announce the Government’s intent to sole source this requirement and determine if any other sources exist. Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit, in writing. Responses must include clear and convincing evidence that competition would be beneficial to the Government and would not be cost or schedule prohibitive. Respondents are responsible for appropriately marking any proprietary information. Responses will not be returned. The contractor shall deliver the following crucial elements: (a) the supply of nitric oxide for inhalation, the pharmaceutical drug essential for the therapy (800 parts per million [PPM]); (b) a specialized Delivery Device that meets the precise criteria outlined in the iNO product label for safe and effective administration, (c) all necessary maintenance and calibration items, accessories, and disposable supplies required for the ongoing operation of the system, and (d) a range of support services, including training, maintenance, pick-up and delivery logistics. This synopsis/notice of intent to sole source is issued in accordance with Federal Acquisition Regulation (FAR) Revolutionary FAR Overhaul (RFO) 5.101 and 12.102 and will be posted for 15 days. Response Due Date: October 22, 2026 by 12:00 PM (CST) Submit to: Contracting Officer: Joe D. Wells at joe.d.wells3.civ@health.mil. .
Similar open opportunities
- Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount ProgramThe Defense Health Agency is asking drug manufacturers to quote discounted prices and refunds on 12 newly FDA-approved brand drugs so its Pharmacy and Therapeutics Committee can…
- Febuxostat TabletsDLA Troop Support wants one national supplier of febuxostat tablets (40 mg and 80 mg, 30-count bottles) for the DoD and VA pharmacy prime vendor programs.
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans to buy Latanoprost eye drops (an ophthalmic solution) for VA, DoD, Bureau of Prisons, Indian Health Service and the Federal Health Care…
- Imatinib TabletsThe Department of Veterans Affairs (National Acquisition Center) plans to award one contract for imatinib mesylate tablets, a cancer drug, to supply VA, DoD, Bureau of Prisons,…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).